[Current indications of stereotaxic interstitial irradiation in acromegaly. Ophthalmologic and neuroendocrinologic correlations in relation to prolonged time].
D000172:Acromegaly / Q000628:therapy*; D000239:Adenoma, Acidophil / Q000150:complications / Q000532:radiotherapy*; D000324:Adrenocorticotropic Hormone / Q000097:blood; D005132:Eye Manifestations; D005500:Follow-Up Studies; D006050:Gold Radioisotopes / Q000627:therapeutic use; D013006:Growth Hormone / Q000097:blood / Q000134:cerebrospinal fluid; D006801:Humans; D007495:Iridium / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local; D009408:Nerve Compression Syndromes / Q000209:etiology; D009900:Optic Nerve; D010910:Pituitary Irradiation / Q000379:methods; D010911:Pituitary Neoplasms / Q000150:complications / Q000000981:diagnostic imaging*; D011859:Radiography; D011868:Radioisotopes / Q000627:therapeutic use; D013238:Stereotaxic Techniques; D014794:Visual Fields; D015021:Yttrium Radioisotopes / Q000627:therapeutic use
D006050:Gold Radioisotopes; D011868:Radioisotopes; D015021:Yttrium Radioisotopes; D007495:Iridium; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone
Les indications actuelles de l'irradiation interstitielle stéréotaxique dans l'acromégalie. Corrélations ophthalmologiques et neuro-endocrinologiques en fonction de reculs prolongés